Nairobi, Kenya – A groundbreaking malaria vaccine rollout in Cameroon is yielding promising results, significantly improving the health of children in the region. At Soa District Hospital, a decrease in malaria cases among vaccinated children has been reported, with mothers noting substantial health improvements.
With approximately 70% of malaria deaths in Cameroon occurring among children under five, the vaccine’s introduction is a critical step forward.
Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance, highlighted the positive outcomes: “When this vaccine is used in combination with other tools and administered at the right time, all cause child mortality reduces, cases declined by 70%, “she stated.
The RTS, S (Mosquirix) vaccine, integrated into Cameroon’s routine immunization schedule, has been instrumental in this progress.
Despite these successes, challenges remain, including coverage levels below targets in some areas and high dropout rates between doses. Officials commented on the matter.
The World Health Organization (WHO) reports that the malaria vaccine rollout in Cameroon is part of a broader effort to combat the disease across Africa.
As of January 2026, 25 countries in Africa have introduced malaria vaccines into their routine immunization programs with support from Gavi, the Vaccine Alliance.
The ongoing support and commitment to the vaccine program are crucial for its sustainability and continued success in reducing malaria’s toll on children in Cameroon and beyond.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Africanews
Source: Rédaction Africanews
